Tetsuya Mitsudomi

<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

Jeffrey A. Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi et al. · Science · 2007 · 4.5K citations · Full text

Medicine, Oncology, Pharmacology +17

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe et al. · The Lancet Oncology · 2009 · 4.1K citations

Medicine, Oncology, Pharmacology +15

Reduced Expression of the <b> <i>let-7</i> </b> MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival

Junichi Takamizawa, Hiroyuki Konishi, Kiyoshi Yanagisawa et al. · Cancer Research · 2004 · 2.4K citations

Medicine, Molecular Biology, Oncology +17

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

Hisashi Saji, Morihito Okada, Masahiro Tsuboi et al. · The Lancet · 2022 · 1.7K citations

Medicine, Oncology, Surgery +13

Mutations of the <b> <i>Epidermal Growth Factor Receptor</i> </b> Gene in Lung Cancer

Takayuki Kosaka, Yasushi Yatabe, Hideki Endoh et al. · Cancer Research · 2004 · 1.2K citations

Medicine, Genetics, Oncology +16